Redmile Group, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share (FOLD)

Filing Manager: Redmile Group, LLC
Reporting Manager: Redmile Group, LLC
Security: Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol: FOLD
Shares outstanding: 308,358,587 shares
Disclosed Ownership: 14,184,495 shares
Ownership: 4.6%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 20:00:35 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Redmile Group, LLC	4.6%	14,184,495	0	14,184,495	/s/ Jeremy C. Green	Managing Member
Jeremy C. Green	4.6%	14,184,495	0	14,184,495	/s/ Jeremy C. Green	Jeremy C. Green